13F filer · CIK 1538653
Prescott General Partners LLC
BOCA RATON, FL · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.7B
+$161.5M vs prior
Positions
9
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $13.1M
Top-10 weight
100.0%
Biggest buys vs Q3 2023
No new or increased positions this quarter.
Biggest sells vs Q3 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | GRINDR INC | -2,280,604 | -100.0% | $-13.1M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2023
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CREDIT ACCEP CORP MICHCOM | 1,560,014 | $831.1M | 47.92% |
| 2 | CIMPRESS PLCSHS EURO | 3,906,492 | $312.7M | 18.03% |
| 3 | WORLD ACCEP CORP DELCOM | 2,037,495 | $266.0M | 15.33% |
| 4 | WAYFAIR INCCL A | 3,823,239 | $235.9M | 13.60% |
| 5 | YELP INCCL A | 918,446 | $43.5M | 2.51% |
| 6 | GLOBAL INDUSTRIAL COMPANYCOM | 1,071,222 | $41.6M | 2.40% |
| 7 | LINEAGE CELL THERAPEUTICS INCOM | 1,851,851 | $2.0M | 0.12% |
| 8 | HUMACYTE INCCOM | 568,246 | $1.6M | 0.09% |
| 9 | AGEX THEREPEUTICS INCCOM | 185,185 | $71.3K | 0.00% |